BridgeBio Pharma Other Long Term Assets (Quarterly) Insights

BridgeBio Pharma, Inc. (BBIO)

68.14 -2.58 (-3.65%) USD | NASDAQ | Feb 20, 16:00

68.70 +0.56 (+0.82%) After-Hours: 20:00

View Other Long Term Assets (Quarterly) for BBIO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Assets (Quarterly) Benchmarks

Start Trial

Insmed, Inc.	Upgrade
Mirum Pharmaceuticals, Inc.	Upgrade
Cogent Biosciences, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Sarepta Therapeutics, Inc.	Upgrade